EODData

MEMBERSHIP REGISTER LOG IN

SHE, 300142: Walvax BioTech

24 Nov 2025
LAST:

12.16

CHANGE:
 0.06		OPEN:
12.13		HIGH:
12.26		ASK:
0.00		VOLUME:
24.24M
CHG(%):
0.50		PREV:
12.10		LOW:
12.10		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
24 Nov 2512.1312.2612.1012.1624.24M
21 Nov 2512.5612.6312.0512.1043.88M
20 Nov 2512.6113.0512.5212.5454.6M
19 Nov 2512.3912.5012.2112.3727.92M
18 Nov 2512.5012.6612.3212.3937.55M
17 Nov 2512.6612.7012.4612.5940.73M
14 Nov 2512.7513.0512.7212.7552.92M
13 Nov 2512.6812.9612.6112.8347.58M
12 Nov 2512.7812.8712.6112.6748.5M
11 Nov 2512.4813.2812.3312.8294.2M

PROFILE

Name:Walvax BioTech
About:Walvax Biotechnology Co., Ltd., researches, develops, produces, and markets vaccines in China. The company offers SARS-CoV-2 mRNA vaccine, an immunization to prevent COVID-19 to individuals 18 years of age and older; 13-valent pneumococcal polysaccharide conjugate vaccine, an invasive diseases caused by streptococcus pneumoniae for use in infants and children 6 weeks through 5 years of age; and recombinant human papillomavirus bivalent vaccine, for the prevention of cervical cancers and precancerous lesions caused by human; 23-valent pneumococcal polysaccharide vaccine, for individuals age 2 years of pneumococcal diseases; ACYW135 meningococcal polysaccharide vaccine, for the prevention of invasive meningococcal diseases; Group A and C meningococcal polysaccharide vaccine, for in adults and children over the age of 2 years and adults to prevent disease caused by the bacterium neisseria meningitidis; Group A and Group C meningococcal conjugate vaccine, for the prevention of invasive meningococcal diseases caused by Neisseria meningitidis serogroups A and C for children 3 months through 5 years of age. It also provides haemophilus influenzae type b conjugate vaccine, for the prevention of invasive infections for children 2 months through 5 years of age; diphtheria, tetanus, and acellular pertussis combined vaccine, for diphtheria and tetanus for infants and children 3 months through 6 years of age. Walvax Biotechnology Co., Ltd. was founded in 2001 and is headquartered in Kunming, China.
Sector:Healthcare
Address:No. 395 Kexin Road, Kunming, China, 650101
Website:https://www.walvax.com
ISIN:CNE100000WN2

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:411.00 
Forward P/E:27.40 
PEG Ratio:27.40 
Price to Sales:8.22 
Price to Book:2.04 
Profit Margin:0.02 
Operating Margin:0.12 
Return on Assets:-0.01 
Return on Equity:-0.01 
DivYield:0.00 
Div/Share:0.01 
Revenue:2.399B 
EBITDA:837.07M 
Shares:1.599B 
Market Cap:19.448B 

TECHNICAL INDICATORS

MA5:12.311.3%
MA10:12.523.0%
MA20:12.291.1%
MA50:11.991.4%
MA100:12.170.1%
MA200:11.604.8%
STO9:6.32 
STO14:8.94 
RSI14:46.59
WPR14:-85.90 
MTM14:-0.04
ROC14:0.00 
ATR:0.38 
Week High:13.057.3%
Week Low:12.050.9%
Month High:13.289.2%
Month Low:11.274.8%
Year High:15.1224.3%
Year Low:9.7025.4%
Volatility:14.19 

RECENT SPLITS

Date Ratio
14 Oct 201530-10
23 Apr 201520-10
30 May 201413-10
07 May 201212-10
05 May 201115-10

RECENT DIVIDENDS

Date Amount
28 May 2025$0.01
30 May 2024$0.01
11 May 2023$0.01
26 Apr 2022$0.03
19 May 2021$0.05
30 Sep 2020$0.02
23 Jul 2019$0.03
23 Apr 2015$0.00
30 May 2014$0.00
19 Jun 2013$0.00